Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2014 Feb 25.
Published in final edited form as: Neurobiol Dis. 2012 Aug 25;0:211–220. doi: 10.1016/j.nbd.2012.08.012

Preferential inactivation of Scn1a in parvalbumin interneurons increases seizure susceptibility

Stacey B Dutton 1, Christopher D Makinson 1, Ligia A Papale 1, Anupama Shankar 1, Bindu Balakrishnan 1, Kazu Nakazawa 2, Andrew Escayg 1
PMCID: PMC3740063  NIHMSID: NIHMS413039  PMID: 22926190

Abstract

Voltage-gated sodium channels (VGSCs) are essential for the generation and propagation of action potentials in electrically excitable cells. Dominant mutations in SCN1A, which encodes the Nav1.1 VGSC α-subunit, underlie several forms of epilepsy, including Dravet syndrome (DS) and genetic epilepsy with febrile seizures plus (GEFS+). Electrophysiological analyses of DS and GEFS+ mouse models have led to the hypothesis that SCN1A mutations reduce the excitability of inhibitory cortical and hippocampal interneurons. To more directly examine the relative contribution of inhibitory interneurons and excitatory pyramidal cells to SCN1A-derived epilepsy, we first compared the expression of Nav1.1 in inhibitory parvalbumin (PV) interneurons and excitatory neurons from P22 mice using fluorescent immunohistochemistry. In the hippocampus and neocortex, 69% of Nav1.1 immunoreactive neurons were also positive for PV. In contrast, 13% and 5% of Nav1.1 positive cells in the hippocampus and neocortex, respectively, were found to co-localize with excitatory cells identified by CaMK2α immunoreactivity. Next, we reduced the expression of Scn1a in either a subset of interneurons (mainly PV interneurons) or excitatory cells by crossing mice heterozygous for a floxed Scn1a allele to either the Ppp1r2-Cre or EMX1-Cre transgenic lines, respectively. The inactivation of one Scn1a allele in interneurons of the neocortex and hippocampus was sufficient to reduce thresholds to flurothyl- and hyperthermia-induced seizures, whereas thresholds were unaltered following inactivation in excitatory cells. Reduced interneuron Scn1a expression also resulted in the generation of spontaneous seizures. These findings provide direct evidence for an important role of PV interneurons in the pathogenesis of Scn1a-derived epilepsies.

Keywords: Epilepsy, SCN1A, ion channels, interneurons, pyramidal neurons

Introduction

Mutations in the voltage-gated sodium channel (VGSC) SCN1A, which encodes the α-subunit of Nav1.1 channels, are responsible for several epilepsy subtypes, including Dravet syndrome (DS) and genetic epilepsy with febrile seizures plus (GEFS+)(Escayg et al., 2000; Claes et al., 2001). Loss-of-function SCN1A mutations cause DS, a debilitating form of epilepsy characterized by complex febrile seizures in the first year of life, partial and/or generalized afebrile epilepsy, intellectual disability, and ataxia (reviewed in Catterall et al., 2010; Escayg & Goldin, 2010). Mutations that cause GEFS+, on the other hand, typically alter the biophysical properties of Nav1.1 channels. GEFS+ is often characterized by febrile seizures that persist beyond six years of age and epilepsy in adulthood (reviewed in Escayg & Goldin, 2010). In addition, a spectrum of seizure types and severities are often observed among affected members of GEFS+ families, as well as between different families (Grant & Vazquez, 2005; Barela et al., 2006; Mahoney et al., 2009).

Emerging data from mouse models of DS and GEFS+ are beginning to provide insight into disease mechanisms. Electrophysiological analyses of dissociated hippocampal and cortical interneurons from Scn1a knockout mice or mice carrying a human SCN1A nonsense mutation (models of DS) revealed reduced sodium currents and cell excitability (Yu et al., 2006; Ogiwara et al., 2007). In contrast, sodium currents are unaltered in pyramidal cells. A role for reduced interneuron excitability in SCN1A-derived epilepsy has also been inferred by electrophysiological data from transgenic and knock-in models expressing the human SCN1A GEFS+ mutation R1648H (Tang et al., 2009; Martin et al., 2010).

Interneurons comprise a highly heterogeneous population of cells that differ in their morphological, functional, and molecular characteristics. Although the expression of SCN1A among interneuron cell-types has not been fully characterized, Ogiwara et al. (2007) reported that the majority of parvalbumin-positive (PV) interneurons in the neocortex and hippocampus express Nav1.1. In support of a functional role of Nav1.1 in PV interneurons, neocortical PV interneurons in an Scn1a mouse model of DS were unable to sustain high-frequency spike amplitudes following increasing current injections (Ogiwara et al., 2007). However, is it unknown whether altered Scn1a expression or function in PV interneurons is sufficient to cause epilepsy. Furthermore, a functional role for Scn1a in pyramidal cells has not been directly examined.

The purpose of this study is to directly compare the contribution of Nav1.1 channels in inhibitory PV interneurons and excitatory pyramidal cells to seizure generation. To achieve this, we first generated mice that were heterozygous for a floxed Scn1a allele. This line was then crossed to transgenic mice that express Cre recombinase in order to preferentially inactivate the heterozygous floxed allele in either PV interneurons or pyramidal neurons of the neocortex and hippocampus. We found that the inactivation of one Scn1a allele in interneurons led to the generation of spontaneous generalized seizures and increased susceptibility to flurothyl- and hyperthermia-induced seizures; whereas seizure thresholds were unchanged following inactivation in pyramidal cells. Taken together, these findings provide evidence for a direct link between the function of Nav1.1 channels in PV interneurons and SCN1A-derived epilepsy subtypes.

Materials and methods

Preparation of the targeting construct

The targeting construct was generated by cloning three PCR-generated fragments with homology to the Scn1a locus into the pFlexible vector (pLoxP-2FRT-PGKneo)(van der Weyden et al., 2005). Fragment 1 (3.8 kb), corresponding to the 5′ arm of homology, was amplified using the primer pair 1F/1R. Fragment 2 (750 bp), containing exon 1 and flanking non-coding sequences, was amplified using the primer pair 2F/2R. Fragment 3 (4.1 kb), the 3′ arm of homology, was amplified using the primer pair 3F/3R (Figure 1A). The assembled targeting construct was sequenced to confirm the absence of unwanted substitutions. Primer sequences are provided in Supplementary Table 1.

Figure 1. Targeting construct and generation of Scn1aFlox/+ mice.

Figure 1

(A) Diagram of the strategy used to generate the floxed Scn1a allele. Homologous recombination between the targeting construct and the endogenous Scn1a locus resulted in the floxed allele in which Scn1a exon 1 is flanked by two LoxP sequences. Pac1, Stu1, and EcoR1 restriction sites, the location of probes for Southern blot analysis, and the lengths of the restriction fragments are shown. LoxP and FRT sites are represented by black and open triangles, respectively.

(B) Southern blot analysis of ES cell genomic DNA. After digestion with Pac1/Stu1, the 5′ internal probe (5′I) detected the predicted 7.8- and 5.6-kb fragments that correspond to the WT and Scn1a-floxed allele, respectively. Fragments of 9.8- and 7.5-kb from the WT and Scn1a-floxed allele, respectively, were detected with the 3′ internal (3′I) and 3′ external (3′E) probes following digestion with EcoR1. Dashed lines above figure, predicted restriction fragments from WT allele; dashed lines below figure, predicted restriction fragments from floxed allele.

Targeting of mouse Scn1a

The targeting construct was linearized with AvrII, gel-purified, and electroporated into 129X1/SvJ-derived PAT-5 embryonic stem (ES) cells at the University of Michigan Transgenic Core. A total of 576 puromycin-resistant clones were selected and screened by PCR amplification for correct targeting of the 3′ arm using the primer F1 located in the puromycin gene, and R1 located in genomic sequence downstream of the 3′ arm. Positive clones were then screened for homologous recombination of the 5′ arm by PCR amplification using primer F4, located in the genomic sequence upstream of the 5′ arm, and the reverse primer R4, located in the puromycin gene. PCR reactions were performed with PCR SuperMix High Fidelity (Invitrogen, Carlsbad, CA) using the recommended conditions. Seven percent targeting efficiency was observed.

Southern blot hybridization

ES cell clones that amplified with both PCR screens were analyzed by Southern blot hybridization (Figure 1B). Ten micrograms of genomic DNA was digested overnight with PacI/StuI or EcoR1, and then separated by agarose gel electrophoresis. Gels were soaked in 0.25 M HCL for 10 min, 0.5 M NaOH/1.5 M NaCl for 20 min, and 1.5 M NaCl/0.5 M Tris (pH 7.5) for 20 min, and then transferred to Hybond-XL membranes (Amersham Biosciences) with 10 X SSC. Membranes were pre-hybridized at 65°C for 2 h in 7% SDS, 0.25 M Na2HPO4 (pH 7.2), and 1 mM EDTA. External probes with homology to the region upstream of the 5′ arm (5′E) and downstream of the 3′ arm (3′E) were PCR-amplified with the primer pairs 5′Fe/5′Re and 3′Fe/3′Re, respectively. Internal probes with homology to the 5′ (5′I) and 3′ (3′I) arms were amplified using the primer pairs 5′Fi/5′Ri and 3′Fi/3′Ri, respectively. Each probe was radiolabeled with [α-32P] CTP using the Megaprime DNA Labeling System (Amersham Biosciences), purified using MicroSpin G-50 columns (Amersham Biosciences), and added to the prehybridization buffer for overnight incubation with the membrane. Membranes were washed twice with 2X SSC/0.1% SDS, once with 1X SSC/0.1% SDS, and once with 0.2X SSC/0.1% SDS at 65°C. Clones identified as correctly targeted were confirmed to have normal karyotypes by chromosome analysis. Southern blot analysis of genomic DNA from tail biopsies of five-week-old mice was performed as described for the ES cell clones.

Generation of mice with a heterozygous floxed allele (Scn1aFlox/+)

Two correctly targeted clones were injected into blastocysts obtained from mating C57BL/6NCrl female mice with (C57BL/6J X DBA/2J) F1 male mice. Male chimeras with a high percentage of agouti coat color were bred to B6;SJL-Tg(ACTFLPe)9205Dym/J females expressing FLP1 recombinase to test for germline transmission of the floxed allele and to delete the puromycin cassette. Scn1aFlox/+; B6;SJL-Tg(ACTFLPe)9205Dym/J male offspring were then bred to C57BL/6J females, and Scn1aFlox/+ N1 males that lacked the FLPe transgene were identified. Using the primer pair X1-F2/X1-R2, the floxed Scn1a allele and the WT allele generated 845-bp and 750-bp PCR products, respectively. Scn1aFlox/+ male mice were then backcrossed three times onto the C57BL/6J background to generate the N4 generation that was used for all subsequent experiments. Mice were maintained at 22°C on a 12-h light/dark cycle, and food and water were available ad libitum. All experiments were performed in accordance with the Institutional Animal Care and Use Committee of Emory University.

Protein extraction

Whole brains from 22-day-old (P22) Scn1aFlox/+ mice and wildtype (WT) littermates were homogenized in 10 ml of 50 mM Tris (pH = 7.5), 10 mM EGTA, and one complete EDTA-free protein inhibitor tablet (Roche). The lysates were centrifuged at 3,500 rpm for 10 min at 4°C. The supernatant was removed and centrifuged at 38,000 rpm for 30 min at 4°C. The pellet, containing the membrane-bound proteins, was suspended in the same buffer used for homogenization, and protein concentration was determined.

Western blot analysis

Western blot analysis was performed on whole brains from P22 mice as previously described (Martin et al., 2010). Briefly, 25 μg of extracted protein was separated on a 7.5% polyacrylamide Tris-HCL gel and transferred to a PVDF membrane. Membranes were blotted with anti-Nav1.1 (Millipore, 1:200) and anti-α-tubulin (Abcam, 1:10,000) antibodies. The secondary antibodies, anti-rabbit IgG (GE, 1:5,000) and anti-mouse IgG (Jackson, 1:5,000), diluted in TBST, were used to identify NaV1.1 and α-tubulin, respectively. The membranes were developed with a chemiluminescent agent (HyGLO Quick Spray, Denville Scientific).

Immunohistochemistry

Immunohistochemistry was performed on three wild-type C57BL/6J mice (P22) to examine the expression of NaV1.1 in PV interneurons and calmodulin-dependent protein kinase (CaMK2α)-positive pyramidal neurons. Mice expressing yellow fluorescence protein (YFP) under the Thy1 promoter (Thy1-YFP) (Jackson Laboratories, Bar Harbor, ME) were also used to analyze the expression of Nav1.1 in excitatory cells. Mice were deeply anesthetized with isoflurane and transcardially perfused. Brains were post-fixed in paraformaldehyde (4%), cryopreserved in 30% sucrose, and 45 μm sections were cut on a cryostat (Leica, Germany). Coronal sections, 400 μm apart, from bregma -0.46 mm to -3.38 mm, were examined. Free-floating sections were washed in TBS/Triton X and blocked in 2% avidin and then 2% biotin. Sections were then incubated with polyclonal rabbit anti-Scn1a (1:50, Millipore) and either monoclonal mouse anti-CaMK2α (1/200, Millipore) or mouse monoclonal anti-parvalbumin (1:1000, Swant). After washing, sections were incubated in secondary antibodies, biotinylated anti-rabbit IgG (1:300, Vector Laboratories) and Alexa Fluor 555 anti-mouse IgG (1:1000, Invitrogen), followed by washing and incubation in fluorescein avidin D (1:300, Vector Laboratories). Negative controls included sections that were not incubated with primary antibody, and sections from P2-3 neonatal mouse pups that do not express detectable levels of Nav1.1. Sections were mounted and visualized using confocal microscopy (Carl Zeiss LSM 510 META). Cells were counted using lmaris software (Bitplane Scientific solutions) on images captured under 40X and 10X magnification. Results from three different animals were combined for the analysis of each sodium channel/cell-type combination.

Generation of heterozygous Scn1a-deleted mice

We used primers and PCR conditions provided by The Jackson Laboratory (Bar Harbor, ME) to screen for the presence of each Cre transgene. Three different Cre transgenic lines were used to excise the floxed Scn1a allele: ZP3-Cre, Ppp1r2-Cre, and EMX1tm(cre)Krj/J -Cre. All Cre transgenic lines were maintained on a C57BL/6J background. A 215-bp PCR product identified mice that were positive for the deleted (inactivated) allele. The ZP3-Cre line, which produces global deletion, was used to demonstrate that the floxed allele could be effectively inactivated. Male Scn1aFlox/+ mice were crossed to female C57BL/6-Tg(Zp3-cre)93Knw/J (ZP3-Cre) mice (Jackson Laboratory, Bar Harbor, ME) expressing Cre recombinase in the female germline. Female offspring carrying the floxed allele and the ZP3-Cre transgene were then crossed to wild-type C57BL/6J males, resulting in offspring that were heterozygous for inactivation of the floxed allele. The EMX1tm(cre)Krj/J (EMX-Cre, Jackson Laboratory, Bar Harbor, ME) and Ppp1r2-Cre (Belforte et al., 2010) lines were used to determine the effect of preferentially inactivating Scn1a from excitatory pyramidal neurons and parvalbumin (PV) inhibitory interneurons in the neocortex and hippocampus, respectively. Specifically, the EMX-Cre line expresses Cre recombinase in glutamatergic neurons in the telencephalon, which includes the neocortex, hippocampus, and amygdala (Gorski et al., 2002), whereas the Ppp1r2-Cre line predominately expresses Cre recombinase in PV inhibitory interneurons in the neocortex and hippocampus (Belforte et al., 2010). Female Scn1aFlox/+ mice (N4 with respect to C57BL/6J) were crossed to either male EMX- or Ppp1r2-Cre mice. Mice that were heterozygous for the floxed allele and carried the Cre transgene (Scn1aFlox/+/Cre+/−) were our experimental mutants. Controls were Scn1aFlox/+ progeny that lacked the Cre transgene (Scn1aFlox/+/Cre−/−), progeny that lacked the targeted allele, but carried the Cre transgene (Scn1a+/+/Cre+/−), and progeny that lacked the targeted allele and the Cre transgene (Scn1a+/+).

Flurothyl seizure induction

Flurothyl seizure induction was performed as previously described (Martin et al., 2010). Briefly, mice (2–3 months old) were placed in a clear acrylic glass chamber and flurothyl (2,2,2-trifluroethylether, Sigma-Aldrich) was introduced at a rate of 20 μl/min. Latencies to the first myoclonic jerk (MJ) and to the generalized tonic-clonic seizure (GTCS) were recorded.

Febrile seizure induction

Thresholds to hyperthermia-induced seizures (a measure of febrile seizure susceptibility) were determined as previously described (Oakley et al., 2009). Briefly, each mouse (P22), placed in an acrylic glass cylinder, was fitted with a rectal temperature probe that was connected to a heating lamp via a temperature controller (TCAT 2DF, Physitemp). The selection of 22-day-old mice for this experiment was based on previous observations that Scn1a mutant mice are highly susceptible to hyperthermia-induced seizures at this age (Oakley et al., 2009, Dutton et al., in preparation). Each mouse was held at 37.5°C for 10 minutes to acclimatize it to the chamber. Body temperature was then elevated by 0.5°C every 2 minutes until either a seizure occurred or a maximum temperature of 42.5°C was reached. Seizure behavior was graded using a modified Racine Scale: 1, staring; 2, head nodding; 3, unilateral forelimb clonus; 4, bilateral forelimb clonus; 5, rearing and falling; 6, generalized seizure. In separate cohorts of mice (P22), seizure induction was coupled with real-time digital video-electroencephalographic (EEG) recordings.

EEG surgery and real-time video/EEG acquisition during febrile seizure induction

Six P22 Scn1aFlox/+/Ppp1r2-Cre+/− mice and four Scn1Flox/+ control mice were anesthetized with isoflurane and surgically implanted with two pairs of stainless steel sterile screw electrodes (0.10 inch in diameter; Pinnacle Technology, Inc.). The first pair of electrodes was placed posterior to bregma in the right hemisphere (EEG1 and EEG2), and the second pair of electrodes was placed at the corresponding positions in the left hemisphere (EEG3 and EEG4). Following electrode placement, fine wires were wrapped tightly around each screw and dental acrylic was applied. Following 2 hours of recovery from surgery, each mouse was subjected to the febrile seizure induction paradigm and real-time video and EEG signals were collected, processed, and digitized at a sampling rate of 200 Hz by the Stellate Harmonie amplifier and software (Natus Medical, Inc.).

EEG surgery and real-time video/EEG/EMG acquisition from freely moving adult mice (P60–90)

Under isoflurane anesthesia, six Scn1aFlox/+/Ppp1r2-Cre+/− mice and seven Scn1Flox/+ control mice were implanted subdurally with four stainless steel sterile screw electrodes (Vintage Machine Supplies, Medina, OH) for EEG acquisition at the following coordinates: Right hemisphere - EEG1; 2 mm anterior-posterior (AP) and 1.2 mm lateral to the midline (LM), EEG2; 1.5 mm AP and 1.2 mm LM, Left hemisphere - EEG3; 0.5 mm AP and 2.2 LM, EEG4; 3.5 mm AP and 2.2 mm LM, and fine-wire electrodes were inserted into the neck muscle for electromyography (EMG) activity as previously described (Martin et al., 2010; Papale et al., 2009). After a minimum of five days recovery from surgery, each mouse was individually placed into an acrylic glass box (15 × 15 × 15 cm) and attached to the EEG system via a small counterbalance (Dragonfly Research). Following 24 hours of acclimatization, each animal was subjected to 96 hours of continuous digital video/EEG/EMG recordings that were collected, processed, and digitized at a sampling rate of 200 Hz by Stellate Harmonie amplifier and software (Natus Medical, Inc.).

EEG/EMG scoring and data analysis

EEG signals were analyzed using a high-pass filter of 0.5 Hz and a low-pass filter of 35 Hz. EMG signals were analyzed using a high-pass filter of 10 Hz and a low-pass filter of 70 Hz. The calibration mark during EEG analysis was 30 μV/mm and 1 second. EEG recordings were manually scored using three different EEG/EMG montages. For the first EEG/EMG montage, the muscle electrode served as the reference for each of the four cortical electrodes (e.g. EEG1-EMG1, Figure 9). To eliminate possible muscle artifacts, the second EEG/EEG montage was generated by referencing the cortical electrodes on the right and left hemispheres to each other (e.g. EEG1-EEG2, Supplementary Figure 2). The third montage was used for the analysis of the EEG data from P22 mice during FS induction. For this montage, the same cortical electrode (EEG4) served as the reference for the other three cortical electrodes (e.g. EEG1- EEG4, Figure 8) since muscle electrodes were not implanted. Epileptiform activity was characterized by the onset of sharp waves that increased in frequency and achieved amplitudes that were at least two times the background with detection in all cortical EEG channels and attenuation of the background rhythm. Simultaneous video recordings enabled the behavior of each animal to be observed during the seizure (Supplementary Videos 1 and 2).

Figure 9. Spontaneous seizures following preferential inactivation of Scn1a in PV interneurons.

Figure 9

(A) Normal EEG pattern from an awake Scn1aFlox/+/Ppp1r2-Cre+/− mutant.

(B) High amplitude single spike discharges (arrows) observed in an Scn1aFlox/+/Ppp1r2-Cre+/− mutant that were associated with jerking movements.

(C) Spontaneous generalized seizure in an Scn1aFlox/+/Ppp1r2-Cre+/− mutant. High amplitude spike discharges were initially observed in the temporal region of the right hemisphere (channel EEG2) with subsequent spread to all EEG channels (between arrows) and abrupt termination and return to normal waveforms. Note that increased muscle tone was observed prior to and following the seizure, indicating that this generalized seizure was associated with a lack of movement. EEG1 and EEG2, EEG recordings from the right cortical hemisphere; EEG3 and EEG4, EEG recordings from the left cortical hemisphere; EMG, electromyographic recording. EEG-EMG montage: four cortical electrodes referenced to the muscle electrode. EMG-EMG montage: both muscle electrodes referenced to each other. Calibration mark: 30 μV/mm and 1 second.

Figure 8. EEG confirmation of hyperthermia-induced seizures.

Figure 8

Representative EEG traces of (A) Twenty-two day old Scn1aFlox/+/Ppp1r2-Cre+/− mouse at the seizure-inducing temperature and (B) Twenty-two day old Scn1aFlox/+/EMX-Cre+/− mouse at the maximum temperature of 42.5°C. Arrows indicate seizure onset and seizure termination in the Scn1aFlox/+/Ppp1r2-Cre+/− mouse. No EEG abnormalities were observed in the Scn1aFlox/+/EMX-Cre+/− mouse. EEG-EEG montage: Three cortical electrodes (EEG1-EEG3) with EEG4 serving as the reference electrode. Calibration mark: 30 μV/mm and 1 second.

Statistical analysis

A one-way analysis of variance (ANOVA) followed by Tukey’s post-hoc analysis was used to identify statistically significant differences in thresholds to flurothyl-induced seizures between mice with restricted deletion of Scn1a and control littermates. Data are represented as mean ± standard error of the mean (SEM). Statistical significance was defined as p < 0.05.

Results

Generation of the floxed Scn1a allele

We generated an Scn1a conditional knock-out mouse model in which exon 1 of the mouse Scn1a gene is flanked by LoxP sites (Figure 1A). Five hundred and seventy six neomycin-resistant ES cell clones were screened for correct targeting by PCR amplification of the 5′ and 3′ regions of homology. Clones that were positive in both PCR assays were also examined by Southern blot analysis. Two correctly targeted ES cell clones were injected into blastocysts to generate chimeric mice that were bred to generate the conditional knock-out mice. The presence of the targeted allele in the resulting lines of mice was confirmed by Southern blot analysis with 5′ and 3′ internal and external probes (Figure 1B).

The floxed allele does not alter Nav1.1 levels

Western blot analysis was performed on protein extracts from whole brains of Scn1aFlox/+ mice and WT littermates to determine whether the presence of the floxed allele affected Nav1.1 protein levels. Figures 2A and 2B show comparable levels of Nav1.1 for both genotypes, demonstrating that the presence of the floxed allele did not alter expression.

Figure 2. The floxed Scn1a allele does not alter Nav1.1 protein levels.

Figure 2

(A) Western blot analysis of whole brain membrane-bound proteins (25 μg) from P22 WT and Scn1aFlox/+ mice shows the expected 260-KDa Nav1.1 band. (B) Quantitative analysis of Nav1.1 levels was performed on three separate Western blots. Nav1.1 protein levels were normalized against α-tubulin as an internal control. OD, optical density. Error bars represent SEM.

The floxed allele does not alter seizure thresholds

Scn1aFlox/+ mice (n = 8) and their WT littermates (n = 9) were evaluated for susceptibility to flurothyl-induced seizures. No differences were observed in latencies to the MJ (WT: 309 ± 12 sec, Scn1aFlox/+: 307 ± 17 sec; p>0.05) or GTCS (WT: 418 ± 17 sec, Scn1aFlox/+: 427 ± 32 sec; p>0.05) between genotypes, indicating that the presence of the floxed allele did not alter seizure thresholds.

Scn1aFlox/+/Zp3-Cre+/− mutants exhibit spontaneous seizures and shortened life spans

Twenty-three Scn1aFlox/+/Zp3-Cre+/− mice were continuously video-recorded from 21 to 28 days of age (total of 168 hours each) and the frequency of spontaneous seizures was determined using the Seizure Scan system (CleverSys, Inc.). The Seizure Scan system provides continuous video recording of freely moving mice. The recorded video files were analyzed using a seizure detection algorithm that is capable of identifying seizure-like behaviors. The detected seizure-like behaviors were then manually examined to confirm the occurrence of a behavioral seizure. Spontaneous seizures were observed in 12 Scn1aFlox/+/Zp3-Cre+/− mice (52.3%) and occurred at an average frequency of three per day. Seizures lasted an average of 35 seconds and were characterized by jumping, repetitive jerking of all four limbs, head nodding, and clonus of the forelimbs and tail. Some behavioral seizures ended with hindlimb extension, typical of severe seizures in the mouse. The average life span of the Scn1aFlox/+/Zp3-Cre+/− mutants was 33 days. The reduced lifespan and spontaneous seizure frequency of the Scn1aFlox/+/Zp3-Cre+/− mutants were similar to heterozygous Scn1a knockout mice (Yu et al., 2006), indicating the effective inactivation of the floxed Scn1a allele. Seizures were not detected in control littermates that lacked the Cre transgene.

Nav1.1 is expressed in PV-interneurons and excitatory cells of the mouse hippocampus and neocortex

Immunohistochemistry was performed on brain sections from P22 mice to determine the relative expression of Nav1.1 in PV-expressing interneurons and CaMK2α and Thy1-YFP expressing excitatory neurons. We found that 69% (234/338) of Nav1.1 immunoreactive cells in the hippocampus were PV-immunoreactive, and most (91%, 234/256) of PV-immunoreactive interneurons in the hippocampus were also Nav1.1 immunoreactive (Figure 3A). However, the extent of co-localization varied between hippocampal regions (Supplementary Figure 1, 10X images). On average, 75% (196/263) of Nav1.1-positive neurons in the CA1, CA3, and the DG regions of the hippocampus were PV-positive, and 91% (196/216) of PV-positive neurons in these regions were also Nav1.1-positive. In the dentate hilus and the stratum radiatum/stratum lacunosum-moleculare (SR/SLM) 47% (7/15) and 52% (31/60) of Nav1.1-immunoreactive cells were PV positive, respectively, while 78% (7/9) of PV-positive cells in the dentate hilus and 97% (38/39) in the SR/SLM co-localized with Nav1.1 immunoreactivity. Thirteen percent (24/179) and 1% (1/74) of Nav1.1-positive cells were CaMK2α-immunoreactive and Thy1-YFP-positive in the hippocampus, respectively (Figure 3B and 3C).

Figure 3. Co-localization of Nav1.1 and cell-type markers in the hippocampus.

Figure 3

(A) Extensive co-localization was observed between Nav1.1 and PV immunoreactivity. (B) Thirteen percent of Nav1.1-postive cells show CaMK2α immunoreactivity. (C) Only 1% of Nav1.1-positive cells co-localize with Thy1-YFP-positive excitatory cells. The images in this figure are from the CA1 region of the hippocampus. Solid arrows, cells that are positive for Nav1.1 and the cell-type marker; Solid arrowheads, Nav1.1-positive cells that are negative for the respective cell-type marker; Open arrowheads, cells that are positive for the cell-type marker and are negative for Nav1.1. Scale bar: 100μm.

Extensive overlap of Nav1.1 and PV immunoreactivity was also detected in the neocortex. We observed that 69% (36/52) of Nav1.1-immunoreactive cells were PV-positive, and 78% (47/60) of PV-positive neurons were immunoreactive for Nav1.1 in layers 2–6 (Figure 4A). In contrast, only 5% (3/62) of Nav1.1-immunoreactive cells were positive for CaMK2α in layers 2–6 of the neocortex (Figure 4B). No co-localization was observed between Nav1.1 and Thy1-YFP-positive excitatory cells in layers 2/3 and 5 of the cortex (0/84) (Figure 4C). Most Thy1-YFP cells were CaMK2α-positive in layers 2/3 and 5 of the hippocampus (94%, 50/53) whereas a relatively small percentage of CaMK2α-positive layer 2/3 and 5 cortical neurons were Thy1-YFP positive (9%, 50/435).

Figure 4. Co-localization of Nav1.1 and cell-type markers in the neocortex.

Figure 4

(A) Extensive co-localization between Nav1.1 and PV immunoreactivity. (B) Five percent of cortical Nav1.1-positive cells show CaMK2α immunoreactivity. (C) Nav1.1 was not detected in Thy1-YFP-positive excitatory cells. Images are of layer 5 neocortical neurons. Arrows indicate co-localization between Nav1.1 and the respective cell-type marker. Solid arrows, cells that are positive for Nav1.1 and the cell-type marker; Solid arrowheads, Nav1.1-positive cells that are negative for the respective cell-type marker; Open arrowheads, cells that are positive for the cell-type marker and are negative for Nav1.1. Scale bar: 100μm.

Preferential inactivation of Scn1a in corticolimbic PV interneurons reduces thresholds to flurothyl-induced seizures

Having observed Nav1.1 expression in PV-positive neurons and excitatory cells of the hippocampus and neocortex, we next examined the effect on seizure thresholds of preferentially reducing the expression of Scn1a in either PV interneurons (Scn1aFlox/+/Ppp1r2-Cre+/− mice) or excitatory pyramidal cells (Scn1aFlox/+/EMX-Cre+/− mice) primarily in the neocortex and hippocampus. Deletion of the heterozygous floxed Scn1a allele by both Cre transgenes was confirmed by the presence of the predicted 215-bp fragment following PCR amplification of tissue from neocortex and hippocampus of Scn1aFlox/+/Ppp1r2-Cre+/− and Scn1aFlox/+/EMX-Cre+/− mice (Figure 5). Mice with preferential deletion of Scn1a from both lines exhibited normal lifespans.

Figure 5. Confirmation of heterozygous Scn1a deletion in the neocortex and hippocampus.

Figure 5

To confirm deletion of the floxed Scn1a allele in mice generated from the (A) Ppp1r2-Cre and (B) EMX-Cre crosses, PCR was performed on genomic DNA isolated from the hippocampus and neocortex of Scn1a+/+, Scn1aFlox/+, and Scn1aFlox/+/Cre+/− mice. PCR products of 750- and 845-bp were generated from the WT and floxed alleles, respectively. The 215-bp PCR product confirmed the deletion of Scn1a exon 1 from the floxed allele.

Thresholds to flurothyl-induced seizures following inactivation of one Scn1a allele in interneurons were determined by comparing seizure latencies between Scn1aFlox/+/Ppp1r2-Cre+/− mice and control littermates (Scn1a+/+, Scn1a+/+/Ppp1r2-Cre+/−, and Scn1aFlox/+). Twelve mice of each genotype were evaluated. Average latencies to the MJ were comparable between all genotypes (Scn1a+/+: 286 ± 9 s, Scn1a+/+/Ppp1r2-Cre+/−: 285 ± 10 s, Scn1aFlox/+: 285 ± 6 s, Scn1aFlox/+/Ppp1r2-Cre+/−: 282 ± 13 s; p = 0.1; Figure 6A). In contrast, the Scn1aFlox/+/Ppp1r2-Cre+/−mutants exhibited a 15–19% reduction in latency to the GTCS compared with the other genotypes (Scn1a+/+: 374 ± 18 s, Scn1a+/+/ Ppp1r2-Cre+/−: 353 ± 18 s, Scn1aFlox/+: 354 ± 15 s, Scn1aFlox/+/Ppp1r2-Cre+/−: 301 ± 10 s, p = 0.0001, Figure 6A).

Figure 6. Preferential inactivation of Scn1a in PV interneurons results in reduced thresholds to flurothyl-induced seizures.

Figure 6

Average latencies in seconds (s) to the MJ and GTCS after exposure to flurothyl in (A) Scn1aFlox/+/Ppp1r2-Cre+/− mice and control littermates (n = 12 per genotype), and (B) Scn1aFlox/+/EMX-Cre+/− mice and control littermates (n = 16–19 per genotype). There was no statistically significant difference in average latency to the MJ between Scn1aFlox/+/Ppp1r2-Cre+/− mutants and control littermates; however, the average latency to the GTCS was significantly shorter in the mutants. No statistically significant differences in average latencies to the MJ and GTCS were observed between Scn1aFlox/+/EMX-Cre+/− mice and control littermates. *, p<0.05, one-way analysis of variance (ANOVA). Error bars represent SEM.

Seizure thresholds were similarly evaluated following the inactivation of the floxed Scn1a allele in excitatory neurons. When the Scn1aFlox/+/EMX-Cre+/− mice (n = 16) were compared to the control littermates (Scn1a+/+ (n = 16), Scn1a+/+/EMX-Cre+/− (n = 19), Scn1aFlox/+ (n = 16)), similar average latencies were observed for the MJ (Scn1a+/+: 287 ± 18 s, Scn1a+/+/EMX-Cre+/−: 333 ± 15 s, Scn1aFlox/+: 322 ± 17 s, Scn1aFlox/+/EMX-Cre+/−: 321 ± 8 s, p = 0.2) and GTCS (Scn1a+/+: 459 ± 26 s, Scn1a+/+/EMX-Cre+/−: 435 ± 14 s, Scn1aFlox/+: 416 ± 18 s, Scn1aFlox/+/EMX-Cre+/−: 433 ± 16 s, p = 0.5) (Figure 6B).

Preferential inactivation of Scn1a in corticolimbic PV interneurons reduces latency to hyperthermia-induced seizures

Given the frequent occurrence of febrile seizures in patients with SCN1A mutations, we also determined whether thresholds for hyperthermia-induced seizures were altered following preferential inactivation of the floxed Scn1a alelle in PV interneurons. The body temperature of Scn1aFlox/+/Ppp1r2-Cre+/− and Scn1aFlox/+ mice (P22–23) was increased by 0.5°C every two minutes, until either a seizure was observed or a maximum temperature of 42.5°C was achieved. All mice were video recorded, and a subset was monitored with simultaneous video-EEG analysis. The latency, severity, and temperature at which the seizure occurred were determined for each mouse. No seizures were observed in Scn1aFlox/+ controls (0/12); in contrast, we detected seizures in 75% (9/12) of the Scn1aFlox/+/Ppp1r2-Cre+/− mutants (Figure 7). The average latency to seizure onset was 701 ± 48 s and occurred at an average temperature of 40.7 ± 0.2°C. Seizures achieved an average Racine score of 2.4 ± 0.1 and were characterized by sudden behavioral arrest, followed by head nodding and/or unilateral forelimb clonus. Behavioral seizures had an average duration of 11 ± 3 s and were associated with spike discharges on the EEG that were at least two times higher than the background (Figure 8A). Supplementary Video 1 provides an example of the behavior exhibited during a hyperthermia-induced seizure.

Figure 7. Preferential inactivation of Scn1a in PV interneurons results in increased susceptibility to hyperthermia-induced seizures.

Figure 7

Hyperthermia-induced seizure thresholds were evaluated in P22 Scn1aFlox/+, Scn1aFlox/+/Ppp1r2-Cre+/− and Scn1aFlox/+/EMX-Cre+/− mice. Twelve mice from each genotype were evaluated. Seizures were not observed in the Scn1aFlox/+ or Scn1aFlox/+/EMX-Cre+/− mice. The percentage of Scn1aFlox/+/Ppp1r2-Cre+/− and Scn1aFlox/+/EMX-Cre+/− mice not exhibiting seizures at each experimental temperature is shown. Seizures were induced in 75% of the Scn1aFlox/+/Ppp1r2-Cre+/− mice at an average temperature of 40.7 ± 0.2.

Thresholds to hyperthermia-induced seizures were similarly examined in Scn1aFlox/+/EMX-Cre+/− mice and Scn1aFlox/+ control littermates. Twelve mice of each genotype were evaluated. Neither genotype exhibited hyperthermia-induced seizures, based on behavioral observations and simultaneous video-EEG analysis (Figure 7, Figure 8B).

Preferential inactivation of Scn1a in corticolimbic PV interneurons leads to spontaneous seizures

Continuous EEG recordings were obtained for 96 hours from each of six Scn1aFlox/+/Ppp1r2-Cre+/− and seven Scn1aFlox/+ mice. Normal EEG patterns consisting of waveforms that increased and decreased in amplitude and frequency and were associated with EMG signals that displayed frequent alterations in muscular tone were observed in all animals (Figure 9A). Interestingly, two episodes of spontaneous seizures were observed in one Scn1aFlox/+/Ppp1r2-Cre+/− mouse prior to the surgical procedure. The seizures, which lasted about seven seconds, involved vocalization accompanied by forelimb and tail clonus. Although we did not detect any spontaneous seizures during the EEG recording of this mouse, rhythmic high amplitude single spike discharges that were often accompanied by sudden jerking movements of the neck and body were observed (Figure 9B, Supplementary Figure 2). In another Scn1aFlox/+/Ppp1r2-Cre+/− mouse, three spontaneous seizures with an average duration of 22 ± 2 seconds were detected. These seizures, which lacked obvious behavioral components, were characterized by high amplitude spike discharges that were first observed in the temporal region of the right hemisphere (EEG2 channel, Figure 9C) with subsequent detection in all EEG channels and abrupt termination and return to normal waveform activity (Figure 9C, Supplementary Video 2). The remaining Scn1aFlox/+/Ppp1r2-Cre+/− mice and the Scn1aFlox/+ control mice did not show any EEG abnormalities.

Discussion

In the current study we generated an Scn1a conditional knockout line that, following global deletion of Scn1a, recapitulated the reduced lifespan and spontaneous seizures observed in the Scn1a knock-out mouse (a model of DS) and the R1648H GEFS+ mouse model (Yu et al., 2006; Martin et al., 2010). The conditional knockout line was then used to determine the effect of preferentially inactivating Nav1.1 from PV interneurons and excitatory cells. We found that preferential inactivation of one Scn1a allele in PV interneurons was sufficient to increase susceptibility to flurothyl- and hyperthermia-induced seizures and lead to spontaneous seizure generation. In contrast, similar inactivation of Scn1a from excitatory cells did not significantly alter seizure thresholds.

In agreement with our findings from the analysis of seizure thresholds, Scn1a expression was detected in a large percentage of PV-interneurons in the hippocampus and neocortex, whereas only a small percentage of Nav1.1-positive cells expressed CaMK2α. Nav1.1 expression in pyramidal cells has been previously reported. Using immunohistochemistry, Ogiwara et al. (2007) observed minor staining of Nav1.1 in the pyramidal cell layer of the hippocampus. In contrast, Gong and colleagues (1999) reported intense immunoreactivity for Nav1.1 in the cell bodies and dendrites of neurons located within the stratum pyramidale, CA1 – CA3 and the molecular layer of the dentate gyrus. In these previous studies, pyramidal cell identity was based on cell morphology and location and Nav1.1 expression was determined from the intensity of the fluorescent signal. In the current study, we determined the percentage of cells that were positive for both Nav1.1 and the pyramidal cell markers, CaMK2α and Thy1. The results from our study are consistent with broad expression of Scn1a in PV interneurons and much more limited expression in pyramidal cells in the hippocampus and cortex.

It is noteworthy that the phenotype of the Scn1aFlox/+/Ppp1r2-Cre+/− mutants was less severe than heterozygous Scn1a knockout mice (Yu et al., 2006) and Scn1aFlox/+/Zp3-Cre+/− mice. Several factors are likely to account for this observation. Firstly, inactivation of the floxed allele was restricted to the forebrain in Scn1aFlox/+/Ppp1r2-Cre+/− mutants whereas global deletion would have occurred on the other lines. Secondly, Belforte et al. (2010) reported that the Ppp1r2-Cre+/− line targets approximately 75% of PV-expressing interneurons in the hippocampus and neocortex. Therefore, incomplete targeting of forebrain PV interneurons would be predicted in Scn1aFlox/+/Ppp1r2-Cre+/− mutants. Thirdly, we observed that approximately 50% of Nav1.1-positive neurons in the hilus and stratum radiatum do not have PV immunoreactivity, suggesting that Scn1a may play a functional role in additional interneuron subtypes. Although the Ppp1r2-Cre+/− line primarily targets PV interneurons, Belforte et al (2010) also observed Cre-mediated deletion in 30% of Reelin-positive interneurons, 15% of neuropeptide Y-expressing interneurons, and some somatostatin-expressing interneurons (Belforte et al., 2010). However, the expression of Scn1a in these and other interneuron subtypes has not been well characterized.

PV interneurons have previously been demonstrated to play a role in other epilepsy models as well as in human epilepsy. Schwaller et al. (2004) reported that PV knockout mice display increased susceptibility to pentylenetetrazole-induced seizures compared with WT littermates. Loss of PV interneurons has also been seen following chemically (Buckmaster & Dudek, 1997) and electrically induced seizures (Gorter et al., 2001). In addition, reduced PV immunoreactivity has been found in several rodent models of epilepsy (Magloczky & Freund, 1995; Scotti et al., 1997; Sloviter et al., 2003) and following recurrent hyperthermia-induced seizures (Kwak et al., 2008). Clinically, patients with intractable temporal lobe epilepsy also show reduced PV expression in resected neocortex (Marco et al., 1996; de Lanerolle et al., 1989). However, it is unclear whether these observed reductions in PV immunoreactivity are due to a decrease in the level of the PV protein itself or indicative of neuronal damage or degeneration.

In addition to epilepsy, altered PV interneuron function has been implicated in the pathophysiology of several neuropsychiatric and neurodevelopmental disorders. Epilepsy and schizophrenia have been shown to be co-morbid (Chang et al., 2011), and post mortem brains of schizophrenia patients show decreased density of PV interneurons (Mirnics et al., 2000; Vawter et al., 2002; Woo et al., 2004). Reduced messenger RNA levels for parvalbumin and decreased density of PV interneurons have also been observed in the hippocampus of post mortem brains of patients with bipolar disorder (Knable et al., 2004). PV interneurons are also important for the generation of gamma (γ) oscillations that occur in the 30–100 Hz frequency range. Altered γ oscillations have been identified in epileptic patients (Kobayashi et al., 2004; Wendling et al., 2002) and rodent models of epilepsy (Ma & Leung, 2002; Medvedev, 2001). Gamma oscillations are also required for working memory function, suggesting that altered PV interneuron function may underlie the impairments in working memory that are observed in disorders such as schizophrenia (Haenschel et al., 2009). In contrast to schizophrenia and bipolar disorder, an increase in the number of PV-immunoreactive interneurons was observed in the CA1 and CA3 regions of the hippocampus in a small study of post mortem brains from five individuals with autism (Lawrence et al., 2010). Interestingly, approximately twenty percent of individuals with autism also develop epilepsy and a de novo missense SCN1A mutation was recently identified in a patient with autism spectrum disorder (O’Roak et al., 2011). Some individuals with Dravet syndrome also display autistic features (Bolton et al., 2011; Genton et al., 2011; Li et al., 2011). Given the importance of Nav1.1 to PV interneuron function, SCN1A should be considered a candidate gene for disorders that are associated with altered PV interneuron function and, in particular, those that are co-morbid with epilepsy.

Finally, it should be noted that while pyramidal cell-specific expression of Scn1a does not appear to play a major role in seizure generation, we cannot exclude the possibility that it may be functionally important and could potentially contribute to other neurological disorders.

Conclusions

In summary, we found that preferential inactivation of one Scn1a allele in PV interneurons of the neocortex and hippocampus results in reduced seizure thresholds, whereas similar inactivation of Scn1a from excitatory neurons does not significantly affect seizure thresholds. This work represents the first direct demonstration of a causal relationship between loss of Nav1.1 in a particular neuronal subtype and seizure susceptibility. The identification of critical neuronal subtypes that contribute to SCN1A-derived disorders could pave the way for the development of novel cell-type specific treatment strategies.

Supplementary Material

01
02. Supplementary Figure 1: Nav1.1 expression in the mouse hippocampus.

WT mouse brain sections were stained with anti-Nav1.1 to determine the expression pattern in various hippocampal regions. Nav1.1 was primarily observed in the CA1, CA3, DG, SLM, and dentate hilus regions of the hippocampus. Spy, Stratum pyramidale; SR, stratum radiatum; SLM, stratum lacunosum-moleculare; DG, dentate gyrus granule layer; Mol, dentate gyrus molecular layer. 10x magnification. Scale bar: 200 μm.

03. Supplementary Figure 2: Single spikes from an awake Scn1aFlox/+/Ppp1r2-Cre+/− mutant were also observed using cortical EEG montage.

High amplitude spike discharges (arrows) were associated with jerking movements. EEG-EEG montage: right and left cortical electrodes referenced to each other eliminated possible muscle artifacts. EMG-EMG montage: muscle electrodes referenced to each other. Calibration mark: 30 μV/mm and 1 second.

04. Video 1: A hyperthermia-induced seizure in a Scn1aFlox/+/Ppp1r2-Cre+/− mouse.

Video 1 provides an example of a hyperthermia-induced seizure that occurred at 41.0°C in a P22 Scn1aFlox/+/Ppp1r2-Cre+/− mouse. During the 25-second event, the mouse exhibited forelimb clonus that progressed to a generalized seizure.

Download video file (63.3MB, avi)
05. Video 2: A spontaneous generalized seizure in a Scn1aFlox/+/Ppp1r2-Cre+/− mouse.

Video 2 provides an example of a spontaneous generalized seizure in a P65 Scn1aFlox/+/Ppp1r2-Cre+/− mouse. The seizure, which lacked an obvious behavioral component, was characterized by high amplitude spike discharges with subsequent detection in all EEG channels and abrupt termination and return to normal waveform activity. EEG-EMG montage: four cortical electrodes referenced to the muscle electrode. EMG-EMG montage: both muscle electrodes referenced to each other. The video is 46 seconds long.

Download video file (5.3MB, mov)

Highlights.

  • Nav1.1 is expressed in most PV interneurons in the neocortex and hippocampus.

  • Nav1.1 is expressed in 5–13% of excitatory cells in neocortex and hippocampus.

  • Preferential inactivation of one Scn1a allele in PV interneurons reduces seizure thresholds.

  • Inactivation of one Scn1a allele in excitatory cells does not alter seizure thresholds.

  • Preferential inactivation of one Scn1a allele in PV interneurons results in spontaneous seizures.

Acknowledgments

We would like to thank the laboratory of Dr. William Catterall for assistance with the hyperthermia seizure induction paradigm and guidance with immunohistochemistry. We are grateful to Cheryl Strauss for editorial assistance. This study was supported by grants from the NIH (R01 NS072221 to AE, and 1F31 NS065694 to SBD) and by a predoctoral fellowship from the Epilepsy Foundation (SBD). This research was also supported in part by the NINDS core facilities grant P30N5055077 to the Emory University Microscopy Core.

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Barela AJ, Waddy SP, Lickfett JG, Hunter J, Anido A, Helmers SL, et al. An epilepsy mutation in the sodium channel SCN1A that decreases channel excitability. J Neurosci. 2006;26:2714–23. doi: 10.1523/JNEUROSCI.2977-05.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Belforte JE, Zsiros V, Sklar ER, Jiang Z, Yu G, Li Y, et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci. 2010;13:76–83. doi: 10.1038/nn.2447. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bolton PF, Carcani-Rathwell I, Hutton J, Goode S, Howlin P, Rutter M. Epilepsy in autism: features and correlates. Br J Psychiatry. 2011;198:289–94. doi: 10.1192/bjp.bp.109.076877. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Buckmaster PS, Dudek FE. Neuron loss, granule cell axon reorganization, and functional changes in the dentate gyrus of epileptic kainate-treated rats. J Comp Neurol. 1997;385:385–404. [PubMed] [Google Scholar]
  5. Catterall WA, Kalume F, Oakley JC. NaV1.1 channels and epilepsy [Review] J Physiol. 2010;588:1849–59. doi: 10.1113/jphysiol.2010.187484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Chang YT, Chen PC, Tsai IJ, Sung FC, Chin ZN, Kuo HT, et al. Bidirectional relation between schizophrenia and epilepsy: A population-based retrospective cohort study. Epilepsia. 2011;52:2036–42. doi: 10.1111/j.1528-1167.2011.03268.x. [DOI] [PubMed] [Google Scholar]
  7. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am J Hum Genet. 2001;68:1327–32. doi: 10.1086/320609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. de Lanerolle NC, Kim JH, Robbins RJ, Spencer DD. Hippocampal interneuron loss and plasticity in human temporal lobe epilepsy. Brain Res. 1989;495:387–95. doi: 10.1016/0006-8993(89)90234-5. [DOI] [PubMed] [Google Scholar]
  9. Escayg A, Goldin AL. Sodium channel Scn1a and epilepsy: mutations and mechanisms [Review] Epilepsia. 2010;51:1650–8. doi: 10.1111/j.1528-1167.2010.02640.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Escayg A, MacDonald BT, Meisler MH, Baulac S, Huberfeld G, An-Gourfinkel I, et al. Mutations of SCN1A, encoding a neuronal sodium channel, in two families with GEFS+2. Nat Genet. 2000;24:343–5. doi: 10.1038/74159. [DOI] [PubMed] [Google Scholar]
  11. Genton P, Velizarova R, Dravet C. Dravet syndrome: the long-term outcome. Epilepsia. 2011;52 (Suppl 2):44–9. doi: 10.1111/j.1528-1167.2011.03001.x. [DOI] [PubMed] [Google Scholar]
  12. Gong B, Rhodes KJ, Bekele-Arcuri Z, Trimmer JS. Type I and type II Na(+) channel alpha-subunit polypeptides exhibit distinct spatial and temporal patterning, and association with auxiliary subunits in rat brain. J Comp Neurol. 1999;412:342–52. [PubMed] [Google Scholar]
  13. Gorski JA, Talley T, Qiu M, Puelles L, Rubenstein JL, Jones KR. Cortical excitatory neurons and glia, but not GABAergic neurons, are produced in the Emx1-expressing lineage. J Neurosci. 2002;22:6309–14. doi: 10.1523/JNEUROSCI.22-15-06309.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gorter JA, van Vliet EA, Aronica E, Lopes da Silva FH. Progression of spontaneous seizures after status epilepticus is associated with mossy fibre sprouting and extensive bilateral loss of hilar parvalbumin and somatostatin-immunoreactive neurons. Eur J Neurosci. 2001;13:657–69. doi: 10.1046/j.1460-9568.2001.01428.x. [DOI] [PubMed] [Google Scholar]
  15. Grant AC, Vazquez B. A case of extended spectrum GEFS+ Epilepsia. 2005;46 (Suppl 10):39–40. doi: 10.1111/j.1528-1167.2005.00357.x. [DOI] [PubMed] [Google Scholar]
  16. Haenschel C, Bittner RA, Waltz J, Haertling F, Wibral M, Singer W, et al. Cortical oscillatory activity is critical for working memory as revealed by deficits in early-onset schizophrenia. J Neurosci. 2009;29:9481–9. doi: 10.1523/JNEUROSCI.1428-09.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Knable MB, Barci BM, Webster MJ, Meador-Woodruff J, Torrey EF. Molecular abnormalities of the hippocampus in severe psychiatric illness: postmortem findings from the Stanley Neuropathology Consortium. Mol Psychiatry. 2004;9:609–20. 544. doi: 10.1038/sj.mp.4001471. [DOI] [PubMed] [Google Scholar]
  18. Kobayashi K, Oka M, Akiyama T, Inoue T, Abiru K, Ogino T, et al. Very fast rhythmic activity on scalp EEG associated with epileptic spasms. Epilepsia. 2004;45:488–96. doi: 10.1111/j.0013-9580.2004.45703.x. [DOI] [PubMed] [Google Scholar]
  19. Kwak SE, Kim JE, Kim SC, Kwon OS, Choi SY, Kang TC. Hyperthermic seizure induces persistent alteration in excitability of the dentate gyrus in immature rats. Brain Res. 2008;1216:1–15. doi: 10.1016/j.brainres.2008.04.026. [DOI] [PubMed] [Google Scholar]
  20. Lawrence YA, Kemper TL, Bauman ML, Blatt GJ. Parvalbumin-, calbindin-, and calretinin-immunoreactive hippocampal interneuron density in autism. Acta Neurol Scand. 2010;121:99–108. doi: 10.1111/j.1600-0404.2009.01234.x. [DOI] [PubMed] [Google Scholar]
  21. Li BM, Liu XR, Yi YH, Deng YH, Su T, Zou X, et al. Autism in Dravet syndrome: prevalence, features, and relationship to the clinical characteristics of epilepsy and mental retardation. Epilepsy Behav. 2011;21:291–5. doi: 10.1016/j.yebeh.2011.04.060. [DOI] [PubMed] [Google Scholar]
  22. Ma J, Leung LS. Metabotropic glutamate receptors in the hippocampus and nucleus accumbens are involved in generating seizure-induced hippocampal gamma waves and behavioral hyperactivity. Behav Brain Res. 2002;133:45–56. doi: 10.1016/s0166-4328(01)00445-4. [DOI] [PubMed] [Google Scholar]
  23. Magloczky Z, Freund TF. Delayed cell death in the contralateral hippocampus following kainate injection into the CA3 subfield. Neuroscience. 1995;66:847–60. doi: 10.1016/0306-4522(94)00613-a. [DOI] [PubMed] [Google Scholar]
  24. Mahoney K, Moore SJ, Buckley D, Alam M, Parfrey P, Penney S, et al. Variable neurologic phenotype in a GEFS+ family with a novel mutation in SCN1A. Seizure. 2009;18:492–7. doi: 10.1016/j.seizure.2009.04.009. [DOI] [PubMed] [Google Scholar]
  25. Marco P, Sola RG, Pulido P, Alijarde MT, Sanchez A, Ramon y Cajal S, et al. Inhibitory neurons in the human epileptogenic temporal neocortex. An immunocytochemical study. Brain. 1996;119 ( Pt 4):1327–47. doi: 10.1093/brain/119.4.1327. [DOI] [PubMed] [Google Scholar]
  26. Martin MS, Dutt K, Papale LA, Dube CM, Dutton SB, de Haan G, et al. Altered function of the SCN1A voltage-gated sodium channel leads to gamma-aminobutyric acid-ergic (GABAergic) interneuron abnormalities. J Biol Chem. 2010;285:9823–34. doi: 10.1074/jbc.M109.078568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Medvedev AV. Temporal binding at gamma frequencies in the brain: paving the way to epilepsy? Australas Phys Eng Sci Med. 2001;24:37–48. doi: 10.1007/BF03178284. [DOI] [PubMed] [Google Scholar]
  28. Mirnics K, Middleton FA, Marquez A, Lewis DA, Levitt P. Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron. 2000;28:53–67. doi: 10.1016/s0896-6273(00)00085-4. [DOI] [PubMed] [Google Scholar]
  29. O’Roak BJ, Deriziotis P, Lee C, Vives L, Schwartz JJ, Girirajan S, et al. Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations. Nat Genet. 2011;43:585–9. doi: 10.1038/ng.835. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Oakley JC, Kalume F, Yu FH, Scheuer T, Catterall WA. Temperature- and age-dependent seizures in a mouse model of severe myoclonic epilepsy in infancy. Proc Natl Acad Sci U S A. 2009;106:3994–9. doi: 10.1073/pnas.0813330106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Ogiwara I, Miyamoto H, Morita N, Atapour N, Mazaki E, Inoue I, et al. Na(v)1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci. 2007;27:5903–14. doi: 10.1523/JNEUROSCI.5270-06.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Papale LA, Beyer B, Jones JM, Sharkey LM, Tufik S, Epstein M, et al. Heterozygous mutations of the voltage-gated sodium channel SCN8A are associated with spike-wave discharges and absence epilepsy in mice. Hum Mol Genet. 2009;18:1633–41. doi: 10.1093/hmg/ddp081. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schwaller B, Tetko IV, Tandon P, Silveira DC, Vreugdenhil M, Henzi T, et al. Parvalbumin deficiency affects network properties resulting in increased susceptibility to epileptic seizures. Mol Cell Neurosci. 2004;25:650–63. doi: 10.1016/j.mcn.2003.12.006. [DOI] [PubMed] [Google Scholar]
  34. Scotti AL, Kalt G, Bollag O, Nitsch C. Parvalbumin disappears from GABAergic CA1 neurons of the gerbil hippocampus with seizure onset while its presence persists in the perforant path. Brain Res. 1997;760:109–17. doi: 10.1016/s0006-8993(97)00309-0. [DOI] [PubMed] [Google Scholar]
  35. Sloviter RS, Zappone CA, Harvey BD, Bumanglag AV, Bender RA, Frotscher M. “Dormant basket cell” hypothesis revisited: relative vulnerabilities of dentate gyrus mossy cells and inhibitory interneurons after hippocampal status epilepticus in the rat. J Comp Neurol. 2003;459:44–76. doi: 10.1002/cne.10630. [DOI] [PubMed] [Google Scholar]
  36. Tang B, Dutt K, Papale L, Rusconi R, Shankar A, Hunter J, et al. A BAC transgenic mouse model reveals neuron subtype-specific effects of a Generalized Epilepsy with Febrile Seizures Plus (GEFS+) mutation. Neurobiol Dis. 2009;35:91–102. doi: 10.1016/j.nbd.2009.04.007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. van der Weyden L, Adams DJ, Harris LW, Tannahill D, Arends MJ, Bradley A. Null and conditional semaphorin 3B alleles using a flexible puroDeltatk loxP/FRT vector. Genesis. 2005;41:171–8. doi: 10.1002/gene.20111. [DOI] [PubMed] [Google Scholar]
  38. Vawter MP, Crook JM, Hyde TM, Kleinman JE, Weinberger DR, Becker KG, et al. Microarray analysis of gene expression in the prefrontal cortex in schizophrenia: a preliminary study. Schizophr Res. 2002;58:11–20. doi: 10.1016/s0920-9964(01)00377-2. [DOI] [PubMed] [Google Scholar]
  39. Wendling F, Bartolomei F, Bellanger JJ, Chauvel P. Epileptic fast activity can be explained by a model of impaired GABAergic dendritic inhibition. Eur J Neurosci. 2002;15:1499–508. doi: 10.1046/j.1460-9568.2002.01985.x. [DOI] [PubMed] [Google Scholar]
  40. Woo TU, Walsh JP, Benes FM. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder. Arch Gen Psychiatry. 2004;61:649–57. doi: 10.1001/archpsyc.61.7.649. [DOI] [PubMed] [Google Scholar]
  41. Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA, et al. Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci. 2006;9:1142–9. doi: 10.1038/nn1754. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01
02. Supplementary Figure 1: Nav1.1 expression in the mouse hippocampus.

WT mouse brain sections were stained with anti-Nav1.1 to determine the expression pattern in various hippocampal regions. Nav1.1 was primarily observed in the CA1, CA3, DG, SLM, and dentate hilus regions of the hippocampus. Spy, Stratum pyramidale; SR, stratum radiatum; SLM, stratum lacunosum-moleculare; DG, dentate gyrus granule layer; Mol, dentate gyrus molecular layer. 10x magnification. Scale bar: 200 μm.

03. Supplementary Figure 2: Single spikes from an awake Scn1aFlox/+/Ppp1r2-Cre+/− mutant were also observed using cortical EEG montage.

High amplitude spike discharges (arrows) were associated with jerking movements. EEG-EEG montage: right and left cortical electrodes referenced to each other eliminated possible muscle artifacts. EMG-EMG montage: muscle electrodes referenced to each other. Calibration mark: 30 μV/mm and 1 second.

04. Video 1: A hyperthermia-induced seizure in a Scn1aFlox/+/Ppp1r2-Cre+/− mouse.

Video 1 provides an example of a hyperthermia-induced seizure that occurred at 41.0°C in a P22 Scn1aFlox/+/Ppp1r2-Cre+/− mouse. During the 25-second event, the mouse exhibited forelimb clonus that progressed to a generalized seizure.

Download video file (63.3MB, avi)
05. Video 2: A spontaneous generalized seizure in a Scn1aFlox/+/Ppp1r2-Cre+/− mouse.

Video 2 provides an example of a spontaneous generalized seizure in a P65 Scn1aFlox/+/Ppp1r2-Cre+/− mouse. The seizure, which lacked an obvious behavioral component, was characterized by high amplitude spike discharges with subsequent detection in all EEG channels and abrupt termination and return to normal waveform activity. EEG-EMG montage: four cortical electrodes referenced to the muscle electrode. EMG-EMG montage: both muscle electrodes referenced to each other. The video is 46 seconds long.

Download video file (5.3MB, mov)

RESOURCES